Arrhythmia Pharmacogenomics: Methodological Considerations
نویسندگان
چکیده
منابع مشابه
Ethical considerations on pharmacogenomics.
Pharmacogenetics offers the prospect of an era of safer and more effective drugs, as well as more individualized use of drug therapies. The effect of human genetic variance on responses to therapy will influence drug-development clinical trials and the use of products in clinical practice. It also promises to raise new ethical challenges, in particular in the fields of research and therapy. Las...
متن کاملPlayware Research – Methodological Considerations
Several sub-disciplines of engineering are driven by the researchers’ aim of providing positive change to the society through their engineering. These researchers are challenged by the traditional research method of experimental research with a waterfall model which demands clearly defined project definition and functional requirements, and impose a sequential processes leading to the final sys...
متن کاملGeneral methodological considerations
I wish to thank Alok Bhargava for organizing a discussion of this interesting paper by Adams et al. My discussion will focus on quite generic philosophical, statistical, and modelling issues that arise when inferring causal e0ects from complex panel and time series data. The analysis of Adams et al. appears to be driven by the following philosophical proposition: when the sample size is large a...
متن کاملEthical considerations in clinical pharmacogenomics research.
In recent years there have been unprecedented advances in our understanding of the involvement of genetic polymorphisms in the response to drug therapies. Polymorphisms have been identified that lead to variable patient responses to several medications including cardiovascular, psychiatric, anti-infective and analgesic therapies. The potential for the development of customized, genotype-based t...
متن کاملPharmacogenomics of CYP2C9: Functional and Clinical Considerations†
CYP2C9 is the most abundant CYP2C subfamily enzyme in human liver and the most important contributor from this subfamily to drug metabolism. Polymorphisms resulting in decreased enzyme activity are common in the CYP2C9 gene and this, combined with narrow therapeutic indices for several key drug substrates, results in some important issues relating to drug safety and efficacy. CYP2C9 substrate s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Pharmaceutical Design
سال: 2009
ISSN: 1381-6128
DOI: 10.2174/138161209789649529